Canada markets open in 4 hours 41 minutes

AbCellera Biologics Inc. (ABCL)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.9000-0.0700 (-1.76%)
At close: 04:00PM EDT
3.9888 +0.09 (+2.28%)
After hours: 07:14PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 1.14B
Enterprise Value 458.65M
Trailing P/E 19.92
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)29.66
Price/Book (mrq)0.99
Enterprise Value/Revenue 12.06
Enterprise Value/EBITDA -2.39

Trading Information

Stock Price History

Beta (5Y Monthly) 0.36
52-Week Change 3-41.27%
S&P500 52-Week Change 322.64%
52 Week High 38.0500
52 Week Low 33.7900
50-Day Moving Average 34.6352
200-Day Moving Average 35.1491

Share Statistics

Avg Vol (3 month) 31.35M
Avg Vol (10 day) 31.18M
Shares Outstanding 5292.78M
Implied Shares Outstanding 6292.78M
Float 8191.76M
% Held by Insiders 128.09%
% Held by Institutions 143.65%
Shares Short (Apr 15, 2024) 423.09M
Short Ratio (Apr 15, 2024) 423.23
Short % of Float (Apr 15, 2024) 410.94%
Short % of Shares Outstanding (Apr 15, 2024) 47.89%
Shares Short (prior month Mar 15, 2024) 423.04M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-719.61%

Management Effectiveness

Return on Assets (ttm)-9.79%
Return on Equity (ttm)-12.27%

Income Statement

Revenue (ttm)38.02M
Revenue Per Share (ttm)0.13
Quarterly Revenue Growth (yoy)-57.40%
Gross Profit (ttm)N/A
EBITDA -212.81M
Net Income Avi to Common (ttm)-146.4M
Diluted EPS (ttm)-0.5100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)760.59M
Total Cash Per Share (mrq)2.6
Total Debt (mrq)77.38M
Total Debt/Equity (mrq)6.72%
Current Ratio (mrq)7.33
Book Value Per Share (mrq)3.96

Cash Flow Statement

Operating Cash Flow (ttm)-43.88M
Levered Free Cash Flow (ttm)-102.96M